The Full-Service
Protein CRDMO

Dual-Engineered Solutions
Delivered at Speed

Join us at PepTalk in San Diego

Ian Fotheringham, Ingenza’s President & Founder, will be presenting at the podium to introduce - “inGenius® Bioprocessing: Reducing Risk, Boosting Titre with ML-Driven Protein Production.”

More Info
January 19-22, 2026 | San Diego, CA + Virtual | Hilton Bayfront San Diego

Proteins

Advanced by nature®

Our deep understanding of nature and the advanced technologies of our inGenius® platform accelerate your product’s journey through key milestones toward commercial success. We are a flexible, reliable and agile partner, offering a bespoke approach for each project.

Ingenza’s impact

100%success rate producing customer targets using one of our hosts
>20xyield enhancement
>7000 Strains/cell-lines and proteins produced
>15xincreased expression
>20years delivering game-changing results

Pharma solutions

Biologics

Ingenza’s technology platforms will accelerate your development pathway, from drug discovery, through pre-clinical evaluation towards first in human, providing tailored solutions at each stage that meet your timeline with support for all your process, material and analytical needs.

Learn more

Pharma solutions

Small molecule

We have a 20 year history of success engineering efficient microbial production of natural products and the biocatalytic regio- and enantio-selective synthesis of small molecule pharmaceuticals, chiral synthons and advanced intermediates.

Learn more

Sustainable biotech

Ingenza is committed to deploying truly sustainable bioprocesses to meet the environmental and Net Zero objectives of our customers in every industry sector. We enable biomanufacturing to achieve efficiencies of industrial performance, competitiveness and robustness that reduce costs and waste, helping our customers benefit fully from their sustainable manufacturing initiatives.

Learn more

The latest from our news and resources

Ingenza Develops Bacillus-Based Protein Production System to Rival E. coli 

Ingenza – a world-leading leading engineering biology CRDMO based in Edinburgh, Scotland – has developed GenXpress Bacillus, a powerful orthogonal protein production system. With performance comparable to the best E. coli expression systems, the new technology offers Ingenza customers a highly productive alternative that…

Continue reading

Nick Challoner Joins Ingenza as Chief Executive Officer

Ingenza Limited, a technology driven contract research, development and manufacturing organisation (CRDMO), recently welcomed Nick Challoner as its new Chief Executive Officer.  Nick is a seasoned leader with more than three decades of experience in innovation, strategy and international business…

Continue reading